Prussian blue and its analogues as artificial enzymes and prospects for their application

Author:

Demkiv O. M.ORCID, ,Stasyuk N. Ye.ORCID,Gayda G. Z.ORCID,Zakalskiy А. E.ORCID,Grynchyshyn N. M.ORCID,Hrytsyna М. R.ORCID,Novikevych O. T.ORCID,Zastryzhna M. L.ORCID,Semiion-Luchyshyn O. V.ORCID,Gonchar M. V.ORCID, , , , , , , , , ,

Abstract

In recent years, Prussian blue nanoparticles (PB-NPs) and theire analogues, that exhibit an increased catalytic activity, have attracted considerable attention in nanotechnology. Such nanoparticles are regarded as an alternative to natural enzymes and are intensively used in biosensorics, diagnostics and experimental biomedicine. Recently, it has been shown that Prussian blue nanoparticles and their analogs, also referred to as “nanozymes”, can be used as active oxygen scavengers and antibacterial or anti-inflammatory drugs due to their polyenzymatic activities, namely oxidase, peroxidase, superoxide dismutase. Their excellent biocompatibility and biodegradability mean that they are ideal for in vivo use. Prussian blue nanoparticles are highly efficient electron transporters that engage in oxidation and reduction activity, which makes them promising mediators and catalysts of reactions. They also show great promise as nanodrug carriers and biological detection sensors due to their large specific surface area, unique chemical characteristics, and variable qualities, which, more importantly, can significantly increase their therapeutic effect. Prussian blue nanoparticles, as therapeutic and diagnostic tools, have achieved significant success in biological nanomedicine. This review is devoted to the methods of synthesis of Prussian blue nanoparticles, the study of their structure, properties and role in the creation of analytical sensors and their promising significance for biomedicine.

Publisher

Ivan Franko National University of Lviv

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3